2400 Skymark Avenue
Unit 6
Mississauga, ON L4W 5K5
Canada
647 476 1350
https://www.profoundmedical.com
Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 131
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Dr. Arun Swarup Menawat MBA, Ph.D. | Chairman of the Board & CEO | 435.87k | N/A | 1955 |
Mr. Rashed Dewan | Chief Financial Officer | 215.18k | N/A | 1968 |
Dr. Mathieu Burtnyk | Chief Operating Officer | 215.18k | N/A | 1982 |
Mr. Hartmut Warnken | Chief Commercial Officer of Outside US | 226.17k | N/A | 1973 |
Mr. Abbey Goodman | Chief Commercial Officer of US | 374.35k | N/A | 1983 |
Mr. Stephen Kilmer | Investor Relations | N/A | N/A | N/A |
Mr. Jacques F. Cornet | Senior VP & Product Leader Sonalleve | N/A | N/A | 1956 |
Mr. Matthew Sobczyk C.A., CPA | Assistant Corporate Controller | N/A | N/A | N/A |
Mr. Levant Tinaz | Software Developer | N/A | N/A | N/A |
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.
Profound Medical Corp.’s ISS governance QualityScore as of 1 May 2024 is 6. The pillar scores are Audit: 5; Board: 5; Shareholder rights: 2; Compensation: 8.